BSE Live
Dec 26, 16:01Prev. Close
2194.25
Open Price
2195.25
Bid Price (Qty.)
2180.00 (18)
Offer Price (Qty.)
2192.10 (2)
NSE Live
Dec 26, 15:24Prev. Close
2193.30
Open Price
2206.00
Bid Price (Qty.)
2192.10 (12)
Offer Price (Qty.)
2193.00 (4)
| Profit & Loss account of Mankind Pharma (in Rs. Cr.) | Mar 09 | Mar 08 | |
| 12 mths | 12 mths | ||
| INCOME | |||
| Revenue From Operations [Gross] | 840.27 | 624.89 | |
| Less: Excise/Sevice Tax/Other Levies | 0.00 | 0.00 | |
| Revenue From Operations [Net] | 840.27 | 624.89 | |
| Total Operating Revenues | 840.27 | 624.89 | |
| Other Income | 19.17 | 11.75 | |
| Total Revenue | 859.45 | 636.64 | |
| EXPENSES | |||
| Cost Of Materials Consumed | 22.98 | 10.63 | |
| Purchase Of Stock-In Trade | 399.52 | 302.44 | |
| Operating And Direct Expenses | 0.42 | 0.34 | |
| Changes In Inventories Of FG,WIP And Stock-In Trade | -18.60 | 11.67 | |
| Employee Benefit Expenses | 104.65 | 76.71 | |
| Finance Costs | 2.38 | 2.47 | |
| Depreciation And Amortisation Expenses | 4.20 | 3.58 | |
| Other Expenses | 158.66 | 118.55 | |
| Total Expenses | 674.21 | 526.39 | |
| Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 185.24 | 110.26 | |
| Exceptional Items | 0.00 | 0.00 | |
| Profit/Loss Before Tax | 185.24 | 110.26 | |
| Tax Expenses-Continued Operations | |||
| Current Tax | 60.04 | 36.00 | |
| Less: MAT Credit Entitlement | 0.00 | 0.00 | |
| Deferred Tax | 0.72 | 1.09 | |
| Tax For Earlier Years | 0.00 | 0.00 | |
| Total Tax Expenses | 64.99 | 40.65 | |
| Profit/Loss After Tax And Before ExtraOrdinary Items | 120.26 | 69.61 | |
| Profit/Loss From Continuing Operations | 120.55 | 69.58 | |
| Profit/Loss For The Period | 120.55 | 69.58 | |
| OTHER ADDITIONAL INFORMATION | |||
| EARNINGS PER SHARE | |||
| Basic EPS (Rs.) | 81.25 | 64.48 | |
| Diluted EPS (Rs.) | 81.25 | 64.48 | |
| VALUE OF IMPORTED AND INDIGENIOUS RAW MATERIALS STORES, SPARES AND LOOSE TOOLS | |||
| Imported Raw Materials | 0.00 | 0.00 | |
| Indigenous Raw Materials | 0.00 | 0.00 | |
| STORES, SPARES AND LOOSE TOOLS | |||
| Imported Stores And Spares | 0.00 | 0.00 | |
| Indigenous Stores And Spares | 0.00 | 0.00 | |
| DIVIDEND AND DIVIDEND PERCENTAGE | |||
| Equity Share Dividend | 5.19 | 3.24 | |
| Tax On Dividend | 0.88 | 0.55 | |
| Equity Dividend Rate (%) | 35.00 | 30.00 |
12.11.2025
Mankind Pharma Standalone September 2025 Net Sales at Rs 2,608.78 crore, up 3.12% Y-o-Y
11.11.2025
07.11.2025
Mankind Pharma Consolidated September 2025 Net Sales at Rs 3,697.16 crore, up 20.17% Y-o-Y
07.11.2025
12.11.2025
Mankind Pharma Standalone September 2025 Net Sales at Rs 2,608.78 crore, up 3.12% Y-o-Y
07.11.2025
Mankind Pharma Consolidated September 2025 Net Sales at Rs 3,697.16 crore, up 20.17% Y-o-Y
01.08.2025
Mankind Pharma Consolidated June 2025 Net Sales at Rs 3,570.35 crore, up 23.4% Y-o-Y
01.08.2025
Mankind Pharma Standalone June 2025 Net Sales at Rs 2,541.36 crore, up 5.75% Y-o-Y